Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 23, Issue 4, Pages 315-330
http://dx.doi.org/10.1155/2007/678793

Biomarkers in Cervical Cancer Screening

Nicolas Wentzensen and Magnus von Knebel Doeberitz

Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, and Scientific Cooperation Unit “Cancer Early Detection”, German Cancer Research Center, Im Neuenheimer Feld 220/221, 69120 Heidelberg, Germany

Received 20 June 2007; Accepted 20 June 2007

Copyright © 2007 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [124 citations]

The following is the list of published articles that have cited the current article.

  • Diane Solomon, Mahboobeh Safaeian, and Philip E. Castle, “Cervical cancer prevention - Cervical screening: Science in evolution,” Obstetrics and Gynecology Clinics of North America, vol. 34, no. 4, pp. 739–+, 2007. View at Publisher · View at Google Scholar
  • Stefanie J. Klug, and Nicolas Wentzensen, “Early Detection of Cervical Carcinomas Finding an Overall Approach,” Deutsches Arzteblatt International, vol. 105, no. 37, pp. 617–U10, 2008. View at Publisher · View at Google Scholar
  • Roberta Zappacosta, and Sandra Rosini, “Cervical Cancer Screening: From Molecular Basis to Diagnostic Practice, Going through New Technologies,” Technology in Cancer Research & Treatment, vol. 7, no. 3, pp. 161–174, 2008. View at Publisher · View at Google Scholar
  • Adriana Aguilar-Lemarroy, Luis F. Jave-Suarez, Pablo C. Ortiz-Lazareno, Gilberto Morgan-Villela, Alejandro Bravo-Cuellar, Vicente Olimon-Andalon, Susana del Toro-Arreola, Georgina Hernandez-Flores, Jose M. Lerma-Diaz, and Jose E. Romero-Ramos, “Apoptosis induction in Jurkat cells and sCD95 levels in women's sera are related with the risk of developing cervical cancer,” Bmc Cancer, vol. 8, 2008. View at Publisher · View at Google Scholar
  • Luciano Mariani, and Sonia Pagliusi, “Vaccination and screening programs: harmonizing prevention strategies for HPV-related diseases,” Journal Of Experimental & Clinical Cancer Research, vol. 27, 2008. View at Publisher · View at Google Scholar
  • Juergen Kupitz, Heike Zimmer, Magnus von Knebel Doeberitz, Eva Hamsikova, Bernhard Heilig, Nicolas Wentzensen, Keng-Ling Wallin, Denise Eschenbach, Tim Waterboer, Miriam Reuschenbach, Joakim Dillner, Michael Pawlita, and Jens Einenkel, “Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers,” International Journal Of Cancer, vol. 123, no. 11, pp. 2626–2631, 2008. View at Publisher · View at Google Scholar
  • Elizabeth R. Unger, Martin A. Whiteside, and Erin M. Siegel, “Human Papillomavirus and Molecular Considerations for Cancer Risk,” Cancer, vol. 113, no. 10, pp. 2981–2994, 2008. View at Publisher · View at Google Scholar
  • Philip E. Castle, Diane Solomon, Debbie Saslow, and Mark Schiffman, “Predicting the Effect of Successful Human Papillomavirus Vaccination on Existing Cervical Cancer Prevention Programs in the United States,” Cancer, vol. 113, no. 10, pp. 3031–3035, 2008. View at Publisher · View at Google Scholar
  • Kristina Nehls, Magnus von Knebel Doeberitz, Dietmar Schmidt, Miriam Reuschenbach, Fjodor Kisseljov, Svetlana Vinokurova, Friedrich Kommoss, Jens Einenkel, and Nicolas Wentzensen, “p16 methylation does not affect protein expression in cervical carcinogenesis,” European Journal Of Cancer, vol. 44, no. 16, pp. 2496–2505, 2008. View at Publisher · View at Google Scholar
  • Allan Hildesheim, John T. Schiller, Diane Solomon, Mark Schiffman, and Douglas R. Lowy, “Human papillomavirus infection and the primary and secondary prevention of cervical cancer,” Cancer, vol. 113, no. 7, pp. 1980–1993, 2008. View at Publisher · View at Google Scholar
  • Simone R. de Souza, Claude Pirmez, Fabio B. Russomano, Alcina F. Nicol, Luciane Velasque, Aparecida Tristao, Gerard J. Nuovo, Beatriz Grinsztejn, Jose R. Lapa e Silva, and Andrea Rodrigues Cordovil Pires, “Cell-cycle and suppressor proteins expression in uterine cervix in HIV/HPV co-infection: comparative study by tissue micro-array (TMA),” Bmc Cancer, vol. 8, 2008. View at Publisher · View at Google Scholar
  • Kate Cuschieri, and Nicolas Wentzensen, “Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia,” Cancer Epidemiology Biomarkers & Prevention, vol. 17, no. 10, pp. 2536–2545, 2008. View at Publisher · View at Google Scholar
  • J. Martin, S. Majka, K. Helm, P. Ruegg, E. Burnham, and M. Varella-Garcia, “Adult lung side population cells have mesenchymal stem cell potential,” Cytotherapy, vol. 10, no. 2, pp. 140–151, 2008. View at Publisher · View at Google Scholar
  • Svetlana Vinokurova, and Magnus von Knebel Doeberitz, “Host Factors in HPV-related Carcinogenesis: Cellular Mechanisms Controlling HPV Infections,” Archives Of Medical Research, vol. 40, no. 6, pp. 435–442, 2009. View at Publisher · View at Google Scholar
  • Alessia Siddu, Paola Cattani, Valerio G. Vellone, Simona Marchetti, Rosaria Santangelo, Gian Franco Zannoni, Sara D'Onghia, and Giovanni Fadda, “RNA (E6 and E7) Assays versus DNA (E6 and E7) Assays for Risk Evaluation for Women Infected with Human Papillomavirus,” Journal Of Clinical Microbiology, vol. 47, no. 7, pp. 2136–2141, 2009. View at Publisher · View at Google Scholar
  • I. Tsoumpou, E. Paraskevaidis, M. Kyrgiou, N. Wentzensen, V. Malamou-Mitsi, P. Martin-Hirsch, G. Koliopoulos, and M. Arbyn, “p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysis,” Cancer Treatment Reviews, vol. 35, no. 3, pp. 210–220, 2009. View at Publisher · View at Google Scholar
  • Mark Schiffman, Mark E. Sherman, Nicolas Wentzensen, and Sophia S. Wang, “Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science,” Gynecologic Oncology, vol. 112, no. 2, pp. 293–299, 2009. View at Publisher · View at Google Scholar
  • Sholom Wacholder, Mark E. Sherman, Sophia S. Wang, Mark Schiffman, Roy Zhang, Rosemary E. Zuna, Michael A. Gold, S. Terence Dunn, Joan Walker, Richard A. Allen, Nicolas Wentzensen, and Jose Jeronimo, “Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma,” International Journal Of Cancer, vol. 124, no. 4, pp. 964–969, 2009. View at Publisher · View at Google Scholar
  • C.J.L.M. Meijer, H. Berkhof, D.A.M. Heideman, A.T. Hesselink, and P.J.F. Snijders, “Validation of high-risk HPV tests for primary cervical screening,” Journal of Clinical Virology, vol. 46, no. 3, pp. S1–S4, 2009. View at Publisher · View at Google Scholar
  • Mark Schiffman, and Diane Solomon, “Screening and Prevention Methods for Cervical Cancer,” Jama-Journal Of The American Medical Association, vol. 302, no. 16, pp. 1809–1810, 2009. View at Publisher · View at Google Scholar
  • Chris J. L. M. Meijer, Folkert J. van Kemenade, Renske D. M. Steenbergen, Bauke Ylstra, Theo J. M. Helmerhorst, Gerrit A. Meijer, Beatriz Carvalho, Peter J. F. Snijders, Saskia M. Wilting, Mark A. van de Wiel, Marianne Tijssen, Maaike C. G. Bleeker, and Wessel N. van Wieringen, “Chromosomal Signatures of a Subset of High-Grade Premalignant Cervical Lesions Closely Resemble Invasive Carcinomas,” Cancer Research, vol. 69, no. 2, pp. 647–655, 2009. View at Publisher · View at Google Scholar
  • Stefanie J. Klug, and Nicolas Wentzensen, “Cervical Cancer Control in the Era of HPV Vaccination and Novel Biomarkers,” Pathobiology, vol. 76, no. 2, pp. 82–89, 2009. View at Publisher · View at Google Scholar
  • Nalini Gupta, Radhika Srinivasan, and Arvind Rajwanshi, “Functional Biomarkers in Cervical Precancer: An Overview,” Diagnostic Cytopathology, vol. 38, no. 8, pp. 618–623, 2010. View at Publisher · View at Google Scholar
  • Mark Schiffman, and Nicolas Wentzensen, “From Human Papillomavirus to Cervical Cancer,” Obstetrics and Gynecology, vol. 116, no. 1, pp. 177–185, 2010. View at Publisher · View at Google Scholar
  • Ruediger Ridder, Karin J. Denton, Marcus J. Trunk, Thomas Keller, Christine Bergeron, and Petra Klement, “The Sensitivity and Specificity of p16(INK4a) Cytology vs HPV Testing for Detecting High-Grade Cervical Disease in the Triage of ASC-US and LSIL Pap Cytology Results,” American Journal Of Clinical Pathology, vol. 134, no. 1, pp. 12–21, 2010. View at Publisher · View at Google Scholar
  • Christine Bergeron, Jaume Ordi, Marcus J. Trunk, Thomas Keller, Dietmar Schmidt, and Ruediger Ridder, “Conjunctive p16(INK4a) Testing Significantly Increases Accuracy in Diagnosing High-Grade Cervical Intraepithelial Neoplasia,” American Journal Of Clinical Pathology, vol. 133, no. 3, pp. 395–406, 2010. View at Publisher · View at Google Scholar
  • Luisa Lina Villa, Cesar Torres, Helena Brentani, Luiz Andre Barreta, Tatiana Rabachini, Alex Fiorini Carvalho, Carina Victoria Manzini Baldi, and Enrique Boccardo, “Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-alpha,” Carcinogenesis, vol. 31, no. 3, pp. 521–531, 2010. View at Publisher · View at Google Scholar
  • Martin Reijans, Guus Simons, Wendy Theelen, Ernst-Jan M. Speel, Frans C. S. Ramaekers, and Anton H. N. Hopman, “A new multiparameter assay to assess HPV 16/18, viral load and physical status together with gain of telomerase genes in HPV-related cancers,” International Journal Of Cancer, vol. 126, no. 4, pp. 959–975, 2010. View at Publisher · View at Google Scholar
  • Eng Hseon Tay, Swee Chong Quek, Jia Liang Li, Elaine H. Lim, Alexander R. Chang, Shi Len Ng, A. Ilancheran, Jeffrey Low, and Joseph Ng, “Cervical dysplasia: Assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy,” Gynecologic Oncology, vol. 119, no. 2, pp. 225–231, 2010. View at Publisher · View at Google Scholar
  • Henrik Griesser, Miriam Reuschenbach, Nikolaus Freudenberg, Frauke Schaffrath, Janina Rahmsdorf, Nicolas Wentzensen, Magnus von Knebel Doeberitz, Andreas Clad, and Christina von Knebel Doeberitz, “Performance of p16(INK4a)-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results,” Gynecologic Oncology, vol. 119, no. 1, pp. 98–105, 2010. View at Publisher · View at Google Scholar
  • R. Zappacosta, D. Caraceni, L. Ciccocioppo, M. Ottaviantonio, F. Conti, S. Andreozzi, F. Petrucci, and S. Rosini, “Is HPV-DNA Testing a Useful Tool in Predicting Low-Grade Squamous Intraepithelial Lesion Outcome? A Retrospective Longitudinal Study,” International Journal of Immunopathology and Pharmacology, vol. 23, no. 1, pp. 317–326, 2010. View at Publisher · View at Google Scholar
  • Thora Pommerencke, Miriam Reuschenbach, Nicolas Wentzensen, Magnus von Knebel Doeberitz, Bernd Lahrmann, and Niels Grabe, “A virtual microscopy system to scan, evaluate and archive biomarker enhanced cervical cytology slides,” Cellular Oncology, vol. 32, no. 1-2, pp. 109–119, 2010. View at Publisher · View at Google Scholar
  • Lilia Patricia Sanchez-Suarez, Marcela Lizano-Soberon, Alejandro Garcia-Carranca, Rafael Andrade-Cruz, Emilio Castellanos-Juarez, Luis Benitez-Bribiesca, Rubicelia Penarroja-Flores, Salvador Vazquez-Vega, and Adriana Contreras-Paredes, “Nuclear co-expression of p14(ARF) and p16(INK4A) in uterine cervical cancer-derived cell lines containing HPV,” Cancer Biomarkers, vol. 8, no. 6, pp. 341–350, 2010. View at Publisher · View at Google Scholar
  • Salvador Vázquez-Vega, Lilia Patricia Sánchez-Suárez, Adriana Contreras-Paredes, Emilio Castellanos-Juárez, Rubicelia Peñarroja-Flores, Marcela Lizano-Soberón, Rafael Andrade-Cruz, Alejandro García-Carrancá, and Luis Benítez-Bribiesca, “Nuclear co-expression of p14ARF and p16INK4A in uterine cervical cancer-derived cell lines containing HPV,” Cancer Biomarkers, vol. 8, no. 6, pp. 341–350, 2010. View at Publisher · View at Google Scholar
  • Vikrant V. Sahasrabuddhe, Nicolas Wentzensen, and Patricia Luhn, “Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts,” Future Microbiology, vol. 6, no. 9, pp. 1083–1098, 2011. View at Publisher · View at Google Scholar
  • Lyndsay A Richardson, Joseph Tota, and Eduardo L Franco, “Optimizing technology for cervical cancer screening in high-resource settings,” Expert Review of Obstetrics and Gynecology, vol. 6, no. 3, pp. 343–353, 2011. View at Publisher · View at Google Scholar
  • M. Nasioutziki, G. Valasoulis, E. Paraskevaidis, M. Kyrgiou, I. Tsoumpou, V. Malamou-Mitsi, G. Koliopoulos, A. Daponte, P. Karakitsos, and C. Founta, “High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: A prospective diagnostic study,” Gynecologic Oncology, vol. 121, no. 1, pp. 49–53, 2011. View at Publisher · View at Google Scholar
  • Philip E. Castle, Walter Kinney, Nicolas Wentzensen, Julia C. Gage, Sholom Wacholder, and Mark Schiffman, “Human Papillomavirus Testing in the Prevention of Cervical Cancer,” Journal of The National Cancer Institute, vol. 103, no. 5, pp. 368–383, 2011. View at Publisher · View at Google Scholar
  • Karen Dresser, Naomi Y. Jiang, Di Lu, Xiaofang Yang, Qin Liu, Kenneth L. Rock, Bruce A. Woda, Arthur M. Mercurio, and Zhong Jiang, “IMP3, a New Biomarker to Predict Progression of Cervical Intraepithelial Neoplasia Into Invasive Cancer,” American Journal Of Surgical Pathology, vol. 35, no. 11, pp. 1638–1645, 2011. View at Publisher · View at Google Scholar
  • N. Wentzensen, “Molecular diagnosis of HPV infections,” Pathologe, vol. 32, no. 6, pp. 461–466, 2011. View at Publisher · View at Google Scholar
  • Kostos Dinas, Panagiotis D. Loufopoulos, George Valasoulis, Maria Kyrgiou, Evaggelos Paraskevaidis, Aristotelis Loufopoulos, Maria Nasioutziki, Angelos Daniilidis, and Petros Karakitsos, “The Evaluation of p16ink4a Immunoexpression/Immunostaining and Human Papillomavirus DNA Test in Cervical Liquid-Based Cytological Samples,” International Journal Of Gynecological Cancer, vol. 21, no. 1, pp. 79–85, 2011. View at Publisher · View at Google Scholar
  • M.D. Post, “Conjunctive p16INK4a Testing Significantly Increases Accuracy in Diagnosing High-Grade Cervical Intraepithelial Neoplasia,” Yearbook of Pathology and Laboratory Medicine, vol. 2011, pp. 87–88, 2011. View at Publisher · View at Google Scholar
  • Marianne Waldstrøm, Rikke Kølby Christensen, and Dorthe Ørnskov, “ Evaluation of p16 INK4a /Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion ,” Cancer Cytopathology, vol. 121, no. 3, pp. 136–145, 2012. View at Publisher · View at Google Scholar
  • Ekaterina S. Jordanova, Folkert J. van Kemenade, Chris J. L. M. Meijer, Peter J. F. Snijders, Bauke Ylstra, Saskia M. Wilting, Wessel N. van Wieringen, Mark A. van de Wiel, Mariska Bierkens, Renske D. M. Steenbergen, Marjolein Bekker-Lettink, and Maaike C. G. Bleeker, “Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection,” International Journal Of Cancer, vol. 131, no. 4, pp. E579–E585, 2012. View at Publisher · View at Google Scholar
  • Rosemary E. Zuna, Joan L. Walker, Katie Smith, Lauren Schwartz, Roy Zhang, Mark Schiffman, S. Terence Dunn, Michael A. Gold, Cara Mathews, Nicolas Wentzensen, and R. Andy Allen, “Performance of p16/Ki-67 Immunostaining to Detect Cervical Cancer Precursors in a Colposcopy Referral Population,” Clinical Cancer Research, vol. 18, no. 15, pp. 4154–4162, 2012. View at Publisher · View at Google Scholar
  • Misaki Wayengera, “Zinc finger arrays binding human papillomavirus types 16 and 18 genomic DNA: precursors of gene-therapeutics for in-situ reversal of associated cervical neoplasia,” Theoretical Biology And Medical Modelling, vol. 9, 2012. View at Publisher · View at Google Scholar
  • Paul K. S. Chan, Lucia Giovannelli, Tak Hong Cheung, Maria Alejandra Picconi, and Jong Sup Park, “Laboratory and clinical aspects of human papillomavirus testing,” Critical Reviews in Clinical Laboratory Sciences, vol. 49, no. 4, pp. 117–136, 2012. View at Publisher · View at Google Scholar
  • Sanam Loghavi, Ann E. Walts, and Shikha Bose, “CINtec® PLUS dual immunostain: A triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion,” Diagnostic Cytopathology, vol. 41, no. 7, pp. 582–587, 2012. View at Publisher · View at Google Scholar
  • Surendra Shastri, Rengaswamy Sankaranarayanan, Bhagwan M. Nene, Christine Carreira Romao, Rohini Kelkar, Bakary S. Sylla, Kasturi Jayant, Tarik Gheit, Massimo Tommasino, Vanessa Tenet, Salvatore Vaccarella, Kedar Deodhar, Silvia Franceschi, Jose Jeronimo, and Sylla G. Malvi, “Prevalence of human papillomavirus types in cervical lesions from women in rural Western India,” Journal Of Medical Virology, vol. 84, no. 7, pp. 1054–1060, 2012. View at Publisher · View at Google Scholar
  • Lu-lu Sun, Xue-mei Cheng, Xian-rong Zhou, Jie Chen, Jia-xin Yang, Zhi-qin Song, Keng Shen, Hui Li, and Dong-yan Cao, “Population-based case-control study on DAPK1, RAR-beta 2 and MGMT methylation in liquid-based cytology,” Archives Of Gynecology And Obstetrics, vol. 285, no. 5, pp. 1433–1439, 2012. View at Publisher · View at Google Scholar
  • O. E. Canessa, J. L. Lopez, J. V. Hidalgo, S. Vighi, M. B. Di Carlo, A. E. Rocher, S. Peressini, F. Guerra, L. A. Palaoro, M. Gamboni, and S. A. Tatti, “AgNOR, p16 and human papillomavirus in low-grade squamous intra-epithelial lesions of the uterine cervix. Preliminary report,” Biotechnic & Histochemistry, vol. 87, no. 4, pp. 257–264, 2012. View at Publisher · View at Google Scholar
  • Frank Struyf, John Doorbar, Heather Griffin, Christine Van Hoof, Wim Quint, Zhonglin Wu, Rebecca Marnane, Brigitte Colau, Anco Molijn, Vincent Dewar, and David Jenkins, “E4 Antibodies Facilitate Detection and Type-Assignment of Active HPV Infection in Cervical Disease,” Plos One, vol. 7, no. 12, 2012. View at Publisher · View at Google Scholar
  • Megan A. Clarke, Robert D. Burk, Arpita Ghosh, Ariana Harari, Sholom Wacholder, Lisa Mirabello, Mark Schiffman, Nicolas Wentzensen, and Attila Lorincz, “Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer,” Cancer Epidemiology Biomarkers & Prevention, vol. 21, no. 12, pp. 2125–2137, 2012. View at Publisher · View at Google Scholar
  • Andre L. P. Abreu, Raquel P. Souza, Fabricia Gimenes, and Marcia E. L. Consolaro, “A review of methods for detect human Papillomavirus infection,” Virology Journal, vol. 9, 2012. View at Publisher · View at Google Scholar
  • Xavier Castellsague, Anil Chaturvedi, Bettie M. Steinberg, Steve Schwartz, Peter J. F. Snijders, Maura L. Gillison, and Laia Alemany, “Human Papillomavirus and Diseases of the Upper Airway: Head and Neck Cancer and Respiratory Papillomatosis,” Vaccine, vol. 30, pp. F34–F54, 2012. View at Publisher · View at Google Scholar
  • N. Wentzensen, C. Sun, A. Ghosh, W. Kinney, L. Mirabello, S. Wacholder, R. Shaber, B. LaMere, M. Clarke, A. T. Lorincz, P. E. Castle, M. Schiffman, and R. D. Burk, “Methylation of HPV18, HPV31, and HPV45 Genomes and Cervical Intraepithelial Neoplasia Grade 3,” JNCI Journal of the National Cancer Institute, vol. 104, no. 22, pp. 1738–1749, 2012. View at Publisher · View at Google Scholar
  • Jolien Roelens, Miriam Reuschenbach, Magnus Von Knebel Doeberitz, Nicolas Wentzensen, Christine Bergeron, and Marc Arbyn, “P16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: A systematic review and meta-analysis,” Cancer Cytopathology, vol. 120, no. 5, pp. 294–307, 2012. View at Publisher · View at Google Scholar
  • Daniela Gustinucci, Valentina D'Angelo, Eugenio Di Dato, Nadia Martinelli, Morena Malaspina, Nicoletta Spita, Beatrice Tintori, Franco Fulciniti, Basilio Passamonti, Elena Cesarini, Daniela Butera, Emiliano Antonio Palmieri, Simonetta Bulletti, Angela Carlani, Maria Staiano, and Maria Rosaria D'Amico, “Role of p16INK4a cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program,” Acta Cytologica, vol. 56, no. 5, pp. 506–514, 2012. View at Publisher · View at Google Scholar
  • Bauke Ylstra, Saskia M. Wilting, Mark A. van de Wiel, Wessel N. van Wieringen, Renske D. M. Steenbergen, Mariska Bierkens, Chris J. L. M. Meijer, and Peter J. F. Snijders, “HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia,” Bmc Cancer, vol. 12, 2012. View at Publisher · View at Google Scholar
  • Dietmar Schmidt, Christina von Knebel Doeberitz, Ruediger Ridder, Miriam Reuschenbach, Svetlana Vinokurova, Friedrich Kommoss, Heike Sartor, Magnus von Knebel Doeberitz, Mirjam Seiz, and Alexander Duwe, “Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells,” International Journal Of Cancer, vol. 130, no. 2, pp. 388–394, 2012. View at Publisher · View at Google Scholar
  • Charlotte A. Brown, Johnannes Bogers, Shaira Sahebali, Christophe E. Depuydt, Frans De Prins, and Douglas P. Malinowski, “Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs,” Journal of Oncology, 2012. View at Publisher · View at Google Scholar
  • Fernando Cobopp. 1–149, 2012. View at Publisher · View at Google Scholar
  • Fernando Cobo, “Clinical utility of HPV testing,” Human Papillomavirus Infections, pp. 87–97, 2012. View at Publisher · View at Google Scholar
  • Cynthia Ann Leaver, Claiborne Miller-Davis, and Gwenyth R. Wallen, “Naturopathic management of females with cervical atypia: A delphi process to explore current practice,” Integrative Medicine Insights, vol. 2012, no. 8, pp. 9–17, 2012. View at Publisher · View at Google Scholar
  • Maura L. Gillison, Xavier Castellsagué, Anil Chaturvedi, Marc T. Goodman, Peter Snijders, Massimo Tommasino, Marc Arbyn, and Silvia Franceschi, “Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix,” International Journal of Cancer, 2013. View at Publisher · View at Google Scholar
  • Wendy Theelen, Rogier J.N.T.M. Litjens, Svetlana Vinokurova, Annick Haesevoets, Martin Reijans, Guus Simons, Frank Smedts, C. Simon Herrington, Frans C.S. Ramaekers, Magnus von Knebel Doeberitz, Ernst-Jan M. Speel, and Anton H.N. Hopman, “Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies,” Human Pathology, 2013. View at Publisher · View at Google Scholar
  • Miriam Reuschenbach, Judith Roos, Dimitrios Panayotopoulos, Stephan E. Baldus, Hans-Georg Schnürch, Annemarie Berger, Karl Ulrich Petry, Matthias Dürst, Mirjam Seiz, Magnus von Knebel Doeberitz, and Monika Hampl, “Characterization of Squamous Cell Cancers of the Vulvar Anterior Fourchette by Human Papillomavirus, p16INK4a, and p53,” Journal of Lower Genital Tract Disease, vol. 17, no. 3, pp. 289–297, 2013. View at Publisher · View at Google Scholar
  • Christian Huisman, G. Bea A. Wisman, Hinke G. Kazemier, Marcel A. T. M. van Vugt, Ate G. J. van der Zee, Ed Schuuring, and Marianne G. Rots, “Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors,” Molecular Oncology, vol. 7, no. 3, pp. 669–679, 2013. View at Publisher · View at Google Scholar
  • Rogier JNTM Litjens, Anton HN Hopman, Koen K Van de Vijver, Frans CS Ramaekers, Roy FPM Kruitwagen, and Arnold-Jan Kruse, “Molecular biomarkers in cervical cancer diagnosis: a critical appraisal,” Expert Opinion on Medical Diagnostics, pp. 1–13, 2013. View at Publisher · View at Google Scholar
  • Mark Schiffman, and Nicolas Wentzensen, “Human papillomavirus infection and the multistage carcinogenesis of cervical cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 22, no. 4, pp. 553–560, 2013. View at Publisher · View at Google Scholar
  • H. Ikenberg, C. Bergeron, D. Schmidt, H. Griesser, F. Alameda, C. Angeloni, J. Bogers, R. Dachez, K. Denton, J. Hariri, T. Keller, M. von Knebel Doeberitz, H. H. Neumann, L. M. Puig-Tintore, M. Sideri, S. Rehm, and R. Ridder, “Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study,” JNCI Journal of the National Cancer Institute, 2013. View at Publisher · View at Google Scholar
  • R. Agami, A. Jaspers, W. Verlaat, R. D. M. Steenbergen, W. N. van Wieringen, G. G. Kenter, M. A. van de Wiel, S. M. Wilting, Y. Yi, C. J. L. M. Meijer, G. A. Meijer, C. le Sage, and P. J. F. Snijders, “Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis,” Oncogene, vol. 32, no. 1, pp. 106–116, 2013. View at Publisher · View at Google Scholar
  • Saskia M. Wilting, Bauke Ylstra, Chris J. L. M. Meijer, Mariska Bierkens, Peter J. F. Snijders, Gerrit A. Meijer, Oscar Krijgsman, Leontien Bosch, Annelieke Jaspers, and Renske D. M. Steenbergen, “Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis,” Genes Chromosomes & Cancer, vol. 52, no. 1, pp. 56–68, 2013. View at Publisher · View at Google Scholar
  • Jiaying Lin, Andreas E. Albers, Jinbao Qin, and Andreas M. Kaufmann, “Prognostic Significance of Overexpressed p16(INK4a) in Patients with Cervical Cancer: A Meta-Analysis,” Plos One, vol. 9, no. 9, 2014. View at Publisher · View at Google Scholar
  • Nicolas Wentzensen, Barbara Fetterman, Diane Tokugawa, Mark Schiffman, Philip E. Castle, Shannon N. Wood, Eric Stiemerling, Nancy Poitras, Thomas Lorey, and Walter Kinney, “Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening,” Cancer Cytopathology, 2014. View at Publisher · View at Google Scholar
  • Shao-Kai Zhang, Le-Ni Kang, Irene J. Chang, Fang-Hui Zhao, Shang-Ying Hu, Wen Chen, Ju-Fang Shi, Xun Zhang, Qin-Jing Pan, Shu-Min Li, and You-Lin Qiao, “The Natural History of Cervical Cancer in Chinese Women: Results from an 11-Year Follow-Up Study in China Using a Multistate Model,” Cancer Epidemiology Biomarkers & Prevention, vol. 23, no. 7, pp. 1298–1305, 2014. View at Publisher · View at Google Scholar
  • Fernando Guerra, Adriana Esther Rocher, José Villacorta Hidalgo, Lilí Díaz, Susana Vighi, Lucía Cardinal, Silvio Tatti, Nicasio Cúneo, Gonzalo Prat Gay, Gabriela Camporeale, and Luis Alberto Palaoro, “Argentophilic nucleolus organizer region as a proliferation marker in cervical intraepithelial neoplasia grade 1 of the uterine cervix,” Journal of Obstetrics and Gynaecology Research, vol. 40, no. 6, pp. 1717–1724, 2014. View at Publisher · View at Google Scholar
  • Renske D. M. Steenbergen, Peter J. F. Snijders, Daniëlle A. M. Heideman, and Chris J. L. M. Meijer, “Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions,” Nature Reviews Cancer, vol. 14, no. 6, pp. 395–405, 2014. View at Publisher · View at Google Scholar
  • Teresa M. Darragh, and David C. Wilbur, “Letter to the Editor – Reply,” Journal of Lower Genital Tract Disease, vol. 18, no. 2, pp. E64–E65, 2014. View at Publisher · View at Google Scholar
  • Hyoung Jin Kim, Seung Cheol Kim, Woong Ju, Yun Hwan Kim, Sun Young Yin, and Hong-Jin Kim, “Aberrant sialylation and fucosylation of intracellular proteins in cervical tissue are critical markers of cervical carcinogenesis,” Oncology Reports, vol. 31, no. 3, pp. 1417–1422, 2014. View at Publisher · View at Google Scholar
  • Elena Allia, Guglielmo Ronco, Anna Coccia, Patrizia Luparia, Luigia Macrì, Corinna Fiorito, Francesca Maletta, Cristina Deambrogio, Sara Tunesi, Laura De Marco, Anna Gillio-Tos, Anna Sapino, and Bruno Ghiringhello, “Interpretation of p16INK4a/Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology,” Cancer Cytopathology, 2014. View at Publisher · View at Google Scholar
  • Maximilian Linxweiler, Florian Bochen, Silke Wemmert, Cornelia Lerner, Andrea Hasenfus, Rainer Maria Bohle, Basel Al-Kadah, Zoltan Ferenc Takacs, Sigrun Smola, and Bernhard Schick, “ Combination of p16 INK4a -Ki67 immunocytology and hpv polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer ,” Cancer Cytopathology, 2014. View at Publisher · View at Google Scholar
  • Sergio Menezes Amaro Filho, Gerard Jerry Nuovo, Cynthia B. Cunha, Luiza de Oliveira Ramos Pereira, Michelle Oliveira-Silva, Fabio Russomano, Andrea Pires, and Alcina F. Nicol, “Correlation of MCM2 detection with stage and virology of cervical cancer,” International Journal Of Biological Markers, vol. 29, no. 4, pp. E363–E371, 2014. View at Publisher · View at Google Scholar
  • Antonio Carlos de Freitas, Eliane Campos Coimbra, and Maria da Conceição Gomes Leitão, “Molecular Targets of HPV Oncoproteins: Potential Biomarkers for Cervical Carcinogenesis,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014. View at Publisher · View at Google Scholar
  • Harrison P. Nguyen, Marigdalia K. Ramírez-Fort, and Peter L. Rady, “The biology of human papillomaviruses,” Current problems in dermatology, vol. 45, pp. 19–32, 2014. View at Publisher · View at Google Scholar
  • N Ramirez, F Guerra, G Camporeale, S Quintana, Lb Diaz, N Cuneo, J Villacorta Hidalgo, Sa Tatti, Lg Alonso, Ss Borkosky, G Prat Gay, and L Palaoro, “Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix,” Biotechnic & Histochemistry, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Johan A. den Boon, Dohun Pyeon, Sophia S. Wang, Mark Horswill, Mark Schiffman, Mark Sherman, Rosemary E. Zuna, Zhishi Wang, Stephen M. Hewitt, Rachel Pearson, Meghan Schott, Lisa Chung, Qiuling He, Paul Lambert, Joan Walker, Michael A. Newton, Nicolas Wentzensen, and Paul Ahlquist, “Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling,” Proceedings of the National Academy of Sciences, vol. 112, no. 25, pp. E3255–E3264, 2015. View at Publisher · View at Google Scholar
  • Christine Bergeron, Hans Ikenberg, Mario Sideri, Karin Denton, Johannes Bogers, Dietmar Schmidt, Francisco Alameda, Thomas Keller, Susanne Rehm, and Ruediger Ridder, “Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results,” Cancer Cytopathology, 2015. View at Publisher · View at Google Scholar
  • Irene Kraus Christiansen, Geir Kjetil Sandve, Martina Schmitz, Matthias Duerst, and Eivind Hovig, “Transcriptionally Active Regions Are the Preferred Targets for Chromosomal HPV Integration in Cervical Carcinogenesis,” Plos One, vol. 10, no. 3, 2015. View at Publisher · View at Google Scholar
  • Margot M Koeneman, Roy FPM Kruitwagen, Hans W Nijman, Brigitte FM Slangen, Toon Van Gorp, and Arnold-Jan Kruse, “Natural history of high-grade cervical intraepithelial neoplasia: a review of prognostic biomarkers,” Expert Review of Molecular Diagnostics, pp. 1–20, 2015. View at Publisher · View at Google Scholar
  • Romy van Baars, Heather Griffin, Zhonglin Wu, Yasmina J. Soneji, Miekel M. van de Sandt, Rupali Arora, Jacolien van der Marel, Bram ter Harmsel, Robert Jach, Krzysztof Okon, Hubert Huras, David Jenkins, Wim G.V. Quint, and John Doorbar, “Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a,” The American Journal of Surgical Pathology, vol. 39, no. 11, pp. 1518–1528, 2015. View at Publisher · View at Google Scholar
  • Márta Benczik, Ádám Galamb, Róbert Koiss, Attila Kovács, Balázs Járay, Tamás Székely, Tímea Szekerczés, Zsuzsa Schaff, Gábor Sobel, and Csaba Jeney, “Claudin-1 as a Biomarker of Cervical Cytology and Histology,” Pathology & Oncology Research, 2015. View at Publisher · View at Google Scholar
  • Mareike Knoer, Konstantin Tziridis, Abbas Agaimy, Johannes Zenk, and Olaf Wendler, “Human Papillomavirus (HPV) Prevalence in Nasal and Antrochoanal Polyps and Association with Clinical Data,” Plos One, vol. 10, no. 10, 2015. View at Publisher · View at Google Scholar
  • Xiaoyi Tian, Di Chen, Ran Zhang, Jun Zhou, Xiaozhong Peng, Xiaolin Yang, Xiuru Zhang, and Zhi Zheng, “Quantitative survey of multiple CpGs from 5 genes identifies CpG methylation panel discriminating between high- and low-grade cervical intraepithelial neoplasia,” Clinical Epigenetics, vol. 7, no. 1, 2015. View at Publisher · View at Google Scholar
  • Georgia Kontostathi, Jerome Zoidakis, Nicholas P. Anagnou, Kalliopi I. Pappa, Antonia Vlahou, and Manousos Makridakis, “Proteomics approaches in cervical cancer: focus on the discovery of biomarkers for diagnosis and drug treatment monitoring,” Expert Review of Proteomics, vol. 13, no. 8, pp. 731–745, 2016. View at Publisher · View at Google Scholar
  • K Pedersen, Sw Sørbye, Is Kristiansen, and Ea Burger, “Using novel biomarkers to triage young adult women with minor cervical lesions: a cost-effectiveness analysis,” BJOG: An International Journal of Obstetrics & Gynaecology, 2016. View at Publisher · View at Google Scholar
  • Hui-Qin Guo, Xiao-Qin Lei, Ze-Ni Wu, Xun Zhang, Shao-Kai Zhang, Lu-Lu Yu, You-Lin Qiao, Wen Chen, Yu Qin, Qin-Jing Pan, and Bai-Feng Chang, “Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: A multicenter study in China,” Oncotarget, vol. 7, no. 16, pp. 21181–21189, 2016. View at Publisher · View at Google Scholar
  • Thomas C. Wright, Catherine M. Behrens, James Ranger-Moore, Susanne Rehm, Abha Sharma, Mark H. Stoler, and Ruediger Ridder, “Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial,” Gynecologic Oncology, 2016. View at Publisher · View at Google Scholar
  • Aparna Mahajan, “Practical issues in the application of p16 immunohistochemistry in diagnostic pathology,” Human Pathology, 2016. View at Publisher · View at Google Scholar
  • Lu-Lu Yu, Xiao-Qin Lei, Yu Qin, Wen Chen, Hui-Qin Guo, Ze-Ni Wu, Le-Ni Kang, Xun Zhang, and You-Lin Qiao, “p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: A 3-year cohort study in China,” Oncotarget, vol. 7, no. 40, pp. 64810–64819, 2016. View at Publisher · View at Google Scholar
  • Ika Kardum-Skelin, Ines Krivak Bolanca, Gordana Kaic, and Biljana Jelic Puskaric, “Viral Infections, Cytological Findings,” Cytopathology, pp. 519–542, 2017. View at Publisher · View at Google Scholar
  • Dong-Ming Wu, Jiao Shi, Teng Liu, Shi-Hua Deng, Rong Han, and Ying Xu, “Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression,” Cancer Biomarkers, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • Ika Kardum-Skelin, Ines Krivak Bolanca, Gordana Kaic, and Biljana Jelic Puskaric, “Viral Infections, Cytological Findings,” Encyclopedia of Pathology, pp. 1–24, 2017. View at Publisher · View at Google Scholar
  • Gitika Panicker, Paul Maranian, Elizabeth R. Unger, Radwa Ewaisha, and Karen S. Anderson, “Serum immune profiling for early detection of cervical disease,” Theranostics, vol. 7, no. 16, pp. 3814–3823, 2017. View at Publisher · View at Google Scholar
  • Androniks Mitildzans, Anastasija Arechvo, Dace Rezeberga, and Sergejs Isajevs, “Expression of p63, p53 and Ki-67 in patients with cervical intraepithelial neoplasia,” Turk Patoloji Dergisi, vol. 33, no. 1, pp. 9–16, 2017. View at Publisher · View at Google Scholar
  • Mary McMenamin, Michael McKenna, and Andrew McDowell, “Clinical Utility of CINtec PLUS Triage in Equivocal Cervical Cytology and Human Papillomavirus Primary Screening,” American Journal of Clinical Pathology, 2018. View at Publisher · View at Google Scholar
  • Ruiyi Zhang, Xuefei Ge, Ke You, Yanli Guo, Hongyan Guo, Yanjie Wang, and Li Geng, “p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions,” Journal of Obstetrics and Gynaecology Research, 2018. View at Publisher · View at Google Scholar
  • Francesca Carozzi, Giovanni Negri, and Cristina Sani, “Molecular Cytology Applications on Gynecological Cytology,” Molecular Applications in Cytology, pp. 127–149, 2018. View at Publisher · View at Google Scholar
  • Peter A Van Dam, Patrick Pauwels, Jose Ferri Gandia, Steven Van Laere, Christian Rolfo, Rossana Ruiz, Christophe Van Berckelaer, Xuan Bich Trinh, and Johannes P Bogers, “Potential new biomarkers for squamous carcinoma of the uterine cervix,” ESMO Open, vol. 3, no. 4, 2018. View at Publisher · View at Google Scholar
  • Packet Bram, Poppe Willy, Weynand Birgit, and Vanherck Miet, “The use of p16/Ki-67 dual staining technology on cervical cytology of patients undergoing a LLETZ procedure,” European Journal of Obstetrics & Gynecology and Reproductive Biology, 2018. View at Publisher · View at Google Scholar
  • Sung Yong Ahn, Young-Min Hyun, Chengri Li, and Xianglan Zhang, “Mitofusin-2 expression is implicated in cervical cancer pathogenesis,” Anticancer Research, vol. 38, no. 6, pp. 3419–3426, 2018. View at Publisher · View at Google Scholar
  • Emmanouil Kalampokas, Fiona Payne, and Mahalakshmi Gurumurthy, “An update on the use of immunohistochemistry and molecular pathology in the diagnosis of pre-invasive and malignant lesions in gynecological oncology,” Gynecologic Oncology, 2018. View at Publisher · View at Google Scholar
  • Karla Calaça Kabbach Prigenzi, Rafael Calil Salim, Thaís Heinke, and Gustavo Rubino De Azevedo Focchi, “Dual p16 and Ki-67 Expression in Liquid-Based Cervical Cytological Samples Compared to Pap Cytology Findings, Biopsies, and HPV Testing in Cervical Cancer Screening: A Diagnostic Accuracy Study,” Acta Cytologica, 2018. View at Publisher · View at Google Scholar
  • Tímea Szekerczés, Ádám Galamb, Adrienn Kocsis, Márta Benczik, Tibor Takács, Attila Martonos, Balázs Járay, András Kiss, Csaba Jeney, Miklós Nyíri, Zsuzsa Schaff, and Gábor Sobel, “Dual-Stained Cervical Cytology and Histology with Claudin-1 and Ki67,” Pathology & Oncology Research, 2018. View at Publisher · View at Google Scholar
  • Yingji Jin, Seung Cheol Kim, Hyoung Jin Kim, Woong Ju, Yun Hwan Kim, and Hong-Jin Kim, “Use of protein-based biomarkers of exfoliated cervical cells for primary screening of cervical cancer,” Archives of Pharmacal Research, 2018. View at Publisher · View at Google Scholar
  • N.A. Parmin, Uda Hashim, Subash C.B. Gopinath, S. Nadzirah, Zulida Rejali, Amilia Afzan, and M.N.A. Uda, “Human Papillomavirus E6 biosensing: Current progression on early detection strategies for cervical Cancer,” International Journal of Biological Macromolecules, 2018. View at Publisher · View at Google Scholar
  • Evangelos Tsiambas, Vasileios Ragos, Christos Riziotis, Nicholas S. Mastronikolis, Stylianos N. Mastronikolis, Anna Batistatou, Efstratios Patsouris, Dimitrios Peschos, Alexandros Mortakis, Grigorios Kyroysis, and Andreas C. Lazaris, “Comparative p16IKN4A expression in laryngeal carcinoma and cervical cancer precursors: A real-time grid-based immunocytochemistry analysis,” Anticancer Research, vol. 38, no. 10, pp. 5805–5810, 2018. View at Publisher · View at Google Scholar
  • Md Kausar Neyaz, and Saman Ahmad, “Biomarkers for the Early Detection of Cervical Cancer,” Preventive Oncology for the Gynecologist, pp. 117–129, 2019. View at Publisher · View at Google Scholar
  • Pakhee Aggarwal, “HPV Infection: Pathogenesis and Detection,” Preventive Oncology for the Gynecologist, pp. 101–115, 2019. View at Publisher · View at Google Scholar
  • Fernando Dias Gonçalves Lima, Janine D Viset, Mariska M G Leeflang, Jacqueline Limpens, Jan M Prins, and Henry J C de Vries, “The Accuracy of Anal Swab–Based Tests to Detect High-Grade Anal Intraepithelial Neoplasia in HIV-Infected Patients: A Systematic Review and Meta-analysis,” Open Forum Infectious Diseases, vol. 6, no. 5, 2019. View at Publisher · View at Google Scholar
  • İlkay Cinar, “The Challenge of Pathological Diagnosis for Precancerous Cervical Lesions,” Middle Black Sea Journal of Health Science, 2019. View at Publisher · View at Google Scholar
  • Sadhana M. Gupta, and Jayanti Mania-Pramanik, “Molecular mechanisms in progression of HPV-associated cervical carcinogenesis,” Journal of Biomedical Science, vol. 26, no. 1, 2019. View at Publisher · View at Google Scholar
  • Wasswa William, Andrew Ware, Annabella Habinka Basaza-Ejiri, and Johnes Obungoloch, “A pap-smear analysis tool (PAT) for detection of cervical cancer from pap-smear images,” BioMedical Engineering OnLine, vol. 18, no. 1, 2019. View at Publisher · View at Google Scholar
  • Wasswa William, Andrew Ware, Annabella Habinka Basaza-Ejiri, and Johnes Obungoloch, “Cervical Cancer Classification from Pap-smears using an Enhanced Fuzzy C-Means Algorithm,” Informatics in Medicine Unlocked, 2019. View at Publisher · View at Google Scholar